Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
Published inThe Lancet HIV, vol. 4, no. 10, p. e433-e441
Publication date2017
Abstract
Keywords
- Acquired Immunodeficiency Syndrome/drug therapy
- Adolescent
- Adult
- Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use
- Female
- HIV Infections/drug therapy
- HIV Protease Inhibitors/administration & dosage/adverse effects/therapeutic use
- HIV-1/drug effects
- Humans
- Lopinavir/administration & dosage/adverse effects/therapeutic use
- Male
- Network Meta-Analysis
- Prospective Studies
- Raltegravir Potassium/administration & dosage/adverse effects/therapeutic use
- Retrospective Studies
- Reverse Transcriptase Inhibitors/administration & dosage/adverse effects/therapeutic use
- Ritonavir/administration & dosage/adverse effects/therapeutic use
Affiliation entities
Research groups
Citation (ISO format)
KANTERS, Steve et al. Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis. In: The Lancet HIV, 2017, vol. 4, n° 10, p. e433–e441. doi: 10.1016/S2352-3018(17)30109-1
Main files (1)
Article (Published version)
Identifiers
- PID : unige:112379
- DOI : 10.1016/S2352-3018(17)30109-1
- PMID : 28784426
Journal ISSN2352-3018